Invivoscribe said May 9 that the deal is aimed at accelerating the molecular diagnostics and precision medicine businesses of both companies. Hitachi’s expertise in measurement and analysis systems technologies is expected to complement Invivoscribe’s technology, assay and bioinformatics development, clinical testing and international regulatory expertise.
“Hitachi manufactures and distributes in-vitro diagnostic instruments that we currently use to standardize testing for the international community; we are looking forward to further deepening our partnership so we can advance precision medicine worldwide,” Invivoscribe CEO Jeffrey Miller, PhD, said in a news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
